These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4148469)

  • 21. [Mechanism and evaluation of salazopyrin therapy].
    Yoshida Y; Munakata A; Aizawa T; Chiba M; Tsuchida S
    Nihon Rinsho; 1977 May; 35(5):1872-6. PubMed ID: 18625
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulphasalazine rectal enemas: topical method of inducing remission of active ulcerative colitis affecting rectum and descending colon.
    Serebro H; Kay S; Javett S; Abrahams C
    Br Med J; 1977 Nov; 2(6097):1264. PubMed ID: 22378
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis.
    Hartley MG; Hudson MJ; Swarbrick ET; Grace RH; Gent AE; Hellier MD
    Aliment Pharmacol Ther; 1996 Apr; 10(2):157-63. PubMed ID: 8730244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medicamentous conservative treatment of ulcerative colitis].
    Martini GA; Arend P
    Chirurg; 1968 Oct; 39(10):442-6. PubMed ID: 4387484
    [No Abstract]   [Full Text] [Related]  

  • 27. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
    Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
    Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal biopsy in ulcerative colitis for evaluating topical hydrocortisone therapy.
    Kratzer GL; Panas PG; Onsanit T
    Dis Colon Rectum; 1973; 16(6):468-72. PubMed ID: 4149065
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
    Cowan GO; Das KM; Eastwood MA
    Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate levels in patients with ulcerative colitis receiving sulphasalazine.
    Schoeman M; Bezuidenhout DJ
    S Afr Med J; 1984 Sep; 66(11):415. PubMed ID: 6148790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rectal effect of salazopyrine in ulcerative colitis during a double-blind study].
    Schulz U; Hanke P; Seige K
    Wien Z Inn Med; 1973; 54(4):185-9. PubMed ID: 4148682
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conservative treatment of ulcerative colitis: late results.
    Nicolaidis C; Kalliterakis E; Kralios N; Antoniou C
    Proc R Soc Med; 1969 Mar; 62(3):262. PubMed ID: 4388780
    [No Abstract]   [Full Text] [Related]  

  • 36. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study.
    Dickinson RJ; King A; Wight DG; Hunter JO; Neale G
    Dis Colon Rectum; 1985 Dec; 28(12):929-30. PubMed ID: 2866071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.
    Riis P; Anthonisen P; Wulff HR; Folkenborg O; Bonnevie O; Binder V
    Scand J Gastroenterol; 1973; 8(1):71-4. PubMed ID: 4144533
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis.
    Dichi I; Frenhane P; Dichi JB; Correa CR; Angeleli AY; Bicudo MH; Rodrigues MA; Victória CR; Burini RC
    Nutrition; 2000 Feb; 16(2):87-90. PubMed ID: 10696629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Azulfidine/Salazopyrin therapy during pregnancy].
    Fahrländer H
    Z Gastroenterol Verh; 1981 Jun; 19():24-6. PubMed ID: 6168128
    [No Abstract]   [Full Text] [Related]  

  • 40. [Local treatment of nonspecific ulcerative colitis].
    Masevich TsG; Zaĭtsev VN
    Sov Med; 1979 Feb; (2):68-72. PubMed ID: 34228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.